Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
uzatresgene autoleucel (ADP-A2M4CD8)
i
Other names:
ADP-A2M4CD8, MAGE-A4ᶜ¹º³²T cell therapy, autologous genetically modified MAGE-A4ᶜ¹º³²T cells, uza-cel, ADPA2M4CD8, ADP A2M4CD8
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Adaptimmune, Galapagos
Drug class:
MAGE-A4 inhibitor, CD8 T-cell agonist
Related drugs:
‹
afamitresgene autoleucel (3)
IMC-C103C (1)
CDR404 (0)
IMA201 (0)
IMA401 (0)
KSH01 (0)
MultiTAA T cell therapy (0)
PDC*lung (0)
RG6129 (0)
TBI 1201 (0)
AB248 (0)
AB821 (0)
EU204 (0)
Human tyrosinase DNA Vaccine (0)
IL-15 DC (0)
IMA203CD8 (0)
LB4330 (0)
NEXI-001 (0)
NEXI-002 (0)
NEXI-003 (0)
SLC-3010 (0)
rhIL-15 (0)
afamitresgene autoleucel (3)
IMC-C103C (1)
CDR404 (0)
IMA201 (0)
IMA401 (0)
KSH01 (0)
MultiTAA T cell therapy (0)
PDC*lung (0)
RG6129 (0)
TBI 1201 (0)
AB248 (0)
AB821 (0)
EU204 (0)
Human tyrosinase DNA Vaccine (0)
IL-15 DC (0)
IMA203CD8 (0)
LB4330 (0)
NEXI-001 (0)
NEXI-002 (0)
NEXI-003 (0)
SLC-3010 (0)
rhIL-15 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
HLA-A*02 + MAGEA4 expression
Solid Tumor
HLA-A*02 + MAGEA4 expression
Solid Tumor
ADP-A2M4CD8
Sensitive: C3 – Early Trials
ADP-A2M4CD8
Sensitive
:
C3
ADP-A2M4CD8
Sensitive: C3 – Early Trials
ADP-A2M4CD8
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login